HOME ABOUT US SERVICES RESEARCH EQUITY DERIVATIVES IPO INTERNET TRADING FTP CONTACT US
  
SENSEX -363.93 -0.51%
71662.22
 
NIFTY -125.75 -0.58%
21585.05
 
Nasdaq 13.77 0.09%
14524.07
 
Nikkei 225 89.13 0.27%
33377.42
 
FTSE 100 -33.50 -0.43%
7689.60
 
YOU ARE ON
Equity
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
 
Aspira Pathlab & Diagnostics Ltd.
 
Source DateBoard Meeting DateDetails
30-Oct-2023 11-Nov-2023 Quarterly Results
26-Jul-2023 12-Aug-2023 Quarterly Results
23-May-2023 27-May-2023 Audited Results & Quarterly Results
06-Feb-2023 14-Feb-2023 Quarterly Results
07-Nov-2022 12-Nov-2022 Quarterly Results
27-Jul-2022 13-Aug-2022 Quarterly Results & A.G.M.
23-May-2022 28-May-2022 Audited Results
07-Feb-2022 12-Feb-2022 Quarterly Results
08-Nov-2021 13-Nov-2021 Quarterly Results
09-Aug-2021 14-Aug-2021 A.G.M. & Quarterly Results
28-May-2021 05-Jun-2021 Audited Results
08-Feb-2021 13-Feb-2021 Quarterly Results
03-Nov-2020 10-Nov-2020 Quarterly Results
25-Aug-2020 29-Aug-2020 A.G.M. & Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2020 ,inter alia, to consider and approve We would like to bring to your notice that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, August 29, 2020. At the said meeting, inter-alia, the following proposal are being placed for consideration/review, for obtaining approval from the shareholders at the ensuing Annual General Meeting of the Company: Raising of funds by way of issue of equity shares through preferential issue, subject to such approval as may be required. This intimation is submitted pursuant to and in terms of Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We would like to bring to your notice that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, August 29, 2020. At the said meeting, inter-alia, the following proposal are being placed for consideration/review, for obtaining approval from the shareholders at the ensuing Annual General Meeting of the Company: Raising of funds by way of issue of equity shares through preferential issue, subject to such approval as may be required.
23-Jul-2020 28-Jul-2020 Preferential Issue of shares & Quarterly Results
08-Jun-2020 13-Jun-2020 Audited Results
27-Jan-2020 04-Feb-2020 Quarterly Results
29-Oct-2019 02-Nov-2019 Quarterly Results
19-Aug-2019 21-Aug-2019 Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2019 ,inter alia, to consider and approve We wish to inform that pursuant to Regulation 29(l)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the board of directors of the Company is scheduled to be held on August 21, 2019 to inter alia discuss and consider issuance and allotment of equity shares by way of preferential allotment, subject to obtaining the approval of the shareholders of the Company in the annual general meeting proposed to be convened. As per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s Code of Conduct for Prevention of Insider Trading as adopted by the Company, the Trading Window for dealing in the securities of the Company will be closed for Designated Persons of the Company from August 01, 2019 till 48 hours after the conclusion of Board Meeting scheduled to be held on August 21, 2019 inter alia discuss and consider issuance and allotment of equity shares by way of preferential allotment. Kindly take the same on record.
14-Aug-2019 14-Aug-2019 Preferential Issue of shares(Cancelled) (Cancelled) Inter alia, to consider and approve issuance and allotment of equity shares by way of preferential allotment, subject to obtaining the approval of the shareholders of the Company in the annual general meeting proposed to be convened
Page 1 of 2
Prev || Next
 
ADINATH STOCK BROKING PVT LTD  :   SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INZ000204337 & DERIVATIVE -INZ000204337 Member ID-3175 National Stock Exchange(NSE): CASH- INZ000204337 & DERIVATIVES -INZ000204337 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INZ000204337 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID 12055200
ADINATH COMMODITIES  :   COMMODITIES SEBI REGISTRATION NUMBERS : INZ000042629 MultiCommodity Exchange Ltd (MCX):Member ID -10140 National Commodity and Derivatives Exchange Ltd (NCDEX):Member ID -00622.
ATTENTION INVESTORS :   "Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :   "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :   "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
ATTENTION INVESTORS :   1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. "Issued in the interest of Investors"
| Disclaimer | Privacy Policy | Feedback | Terms and Conditions | Careers | Investor Grievances | Download | Investor Protection | SCORES | Site Map
Investor Charter - DP | Investor Charter - Stock Broker | e-voting | Investor Education
Useful links: NSE | BSE | MCX-SX | CDSL | SEBI | MCX | NCDEX | FMC | Smart ODR
SEBI Registration No.INZ000042629
Copyright © 2011 Adinath Stock Broking Pvt Ltd                             Designed, Developed & Content Powered By ●●● Accord Fintech Pvt.Ltd.